Immediate Impact
56 standout
Citing Papers
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
Works of Jungyun Hwang being referenced
Surveillance of patients with cirrhosis remains suboptimal in the United States
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Jungyun Hwang | 146 | 113 | 130 | 144 | 140 | 26 | 830 | |
| BumChul Yoon | 91 | 32 | 35 | 218 | 92 | 67 | 838 | |
| Valério Bonavolontá | 90 | 180 | 69 | 63 | 35 | 42 | 707 | |
| Michael Villiger | 257 | 66 | 28 | 151 | 91 | 14 | 867 | |
| Lina Bunketorp Käll | 57 | 79 | 96 | 157 | 38 | 49 | 796 | |
| I‐Hua Chu | 206 | 85 | 98 | 58 | 45 | 34 | 954 | |
| Angelo Rodio | 95 | 27 | 56 | 104 | 32 | 55 | 654 | |
| Robert O. Ruhling | 266 | 89 | 110 | 107 | 42 | 28 | 945 | |
| Benjamin H. Massey | 222 | 96 | 49 | 62 | 51 | 51 | 934 | |
| Peter C. Douris | 131 | 74 | 36 | 103 | 47 | 35 | 759 | |
| Félix Berrigan | 161 | 70 | 169 | 52 | 31 | 25 | 979 |
All Works
Login with ORCID to disown or claim papers
Loading papers...